Company Filing History:
4 out of 1,540 
1 out of 306 
1 out of 276 
Years Active: 2007-2010
Title: The Innovative Contributions of Marcus Kostka
Introduction
Marcus Kostka is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating neurodegenerative diseases. With a total of 5 patents to his name, Kostka's work is recognized for its potential impact on healthcare.
Latest Patents
Among his latest patents, Kostka has developed substituted 1,2-ethylenediamines, which are described in his patent as having applications in the treatment of Alzheimer's disease and similar conditions. This invention outlines a general formula for these compounds and details their therapeutic uses. Another significant patent involves a method for treating diseases associated with altered levels of amyloid beta peptides. This method focuses on administering compounds that can effectively manage conditions related to amyloid beta peptide isoforms and plaque formation in mammals.
Career Highlights
Throughout his career, Kostka has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Vetmedica GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Kostka has collaborated with several professionals in his field, including Klaus Klinder and Cornelia Dorner-Ciossek. These collaborations have likely enhanced his research and development efforts, leading to the successful patents he holds today.
Conclusion
Marcus Kostka's innovative work in medicinal chemistry and his contributions to the treatment of Alzheimer's disease highlight his importance as an inventor. His patents reflect a commitment to advancing healthcare solutions and improving the quality of life for patients.